A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them.

Pharmaceutical companies may try to cap the price hike in future.

Elon Musk’s Neuralink Demonstrates ‘Telepathic Typing’ in Monkeys

The neuroscience startup says it should be ready for human trials in six months during a…

Elon Musk’s Neuralink Set to ‘Show and Tell’ Latest Brain-Computer Advances at Event

Technique The startup, which aims to help people with neurological conditions or others by decoding brain…

New Alzheimer’s Drug Shows Positive Results but Side Effects

Health Eisai and Biogen’s drug slowed cognitive decline in study volunteers, but many had bleeding, swelling…

Opinion | The FDA and an ALS Treatment

Few diseases are as cruelly debilitating as amyotrophic lateral sclerosis (ALS). But a Food and Drug…

FTC Appeals Judge’s Dismissal of Suit Against Illumina Deal

By Dave Michaels and Peter Loftus Updated Sept. 2, 2022 5:02 pm ET Listen to article…

FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease

The Food and Drug Administration approved a gene therapy from Bluebird Bio Inc. that represents a…

Labcorp to Spin Off Clinical-Development Business

Updated July 28, 2022 7:28 am ET Listen to article (2 minutes) Laboratory Corp. of America…

Long Covid is an elusive target for Big Pharma

This is the second column in the three-part Heard on the Street series on Long Covid.…

Merck COVID-19 pill frequently prescribed in some countries despite low efficacy

In some countries, doctors are often prescribing Kovid-19 antivirals Merck & Co., Security AS Concerns about…